Cargando…

Resveratrol and FGF1 Synergistically Ameliorates Doxorubicin-Induced Cardiotoxicity via Activation of SIRT1-NRF2 Pathway

Doxorubicin (DOX) has received attention due to dose-dependent cardiotoxicity through abnormal redox cycling. Native fibroblast growth factor 1 (FGF1) is known for its anti-oxidative benefits in cardiovascular diseases, but possesses a potential tumorigenic risk. Coincidentally, the anti-proliferati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Guangping, Liu, Qingbo, Gao, Ting, Li, Jiahao, Zhang, Jingjing, Chen, Ou, Cao, Cong, Mao, Min, Xiao, Mengjie, Zhang, Xiaohui, Wang, Jie, Guo, Yuanfang, Tang, Yufeng, Gu, Junlian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9572068/ https://www.ncbi.nlm.nih.gov/pubmed/36235670 http://dx.doi.org/10.3390/nu14194017

Ejemplares similares

Cardiac SIRT1 ameliorates doxorubicin-induced cardiotoxicity by targeting sestrin 2
por: Wang(a), Jie, et al.
Publicado: (2022)

Co-Treatment With Resveratrol and FGF1 Protects Against Acute Liver Toxicity After Doxorubicin Treatment via the AMPK/NRF2 Pathway
por: Xu, Xianchou, et al.
Publicado: (2022)

A new FGF1 variant protects against adriamycin-induced cardiotoxicity via modulating p53 activity
por: Xiao, Mengjie, et al.
Publicado: (2021)

p53 at the Crossroads between Doxorubicin-Induced Cardiotoxicity and Resistance: A Nutritional Balancing Act
por: Guo, Yuanfang, et al.
Publicado: (2023)

Resveratrol Attenuates High Glucose-Induced Osteoblast Dysfunction via AKT/GSK3β/FYN-Mediated NRF2 Activation
por: Xuan, Yue, et al.
Publicado: (2022)

NRF2-Related Epigenetic Modifications in Cardiac and Vascular Complications of Diabetes Mellitus
por: Wang, Jie, et al.
Publicado: (2021)

Protection against Doxorubicin-Related Cardiotoxicity by Jaceosidin Involves the Sirt1 Signaling Pathway
por: Liu, Yuzhou, et al.
Publicado: (2021)

Resveratrol, a polyphenol phytoalexin, protects against doxorubicin-induced cardiotoxicity
por: Gu, Jun, et al.
Publicado: (2015)

Resveratrol solid lipid nanoparticles to trigger credible inhibition of doxorubicin cardiotoxicity
por: Zhang, Lili, et al.
Publicado: (2019)

Nrf2: a dark horse in doxorubicin-induced cardiotoxicity
por: Zhao, Xiaopeng, et al.
Publicado: (2023)

Tubeimoside I Ameliorates Doxorubicin-Induced Cardiotoxicity by Upregulating SIRT3
por: Zhang, Wei, et al.
Publicado: (2023)

Nrf2 Deficiency Exaggerates Doxorubicin-Induced Cardiotoxicity and Cardiac Dysfunction
por: Li, Siying, et al.
Publicado: (2014)

Protective Effects of Oroxylin A against Doxorubicin-Induced Cardiotoxicity via the Activation of Sirt1 in Mice
por: Zhang, Wen-Bin, et al.
Publicado: (2021)

Roflumilast Attenuates Doxorubicin-Induced Cardiotoxicity by Targeting Inflammation and Cellular Senescence in Cardiomyocytes Mediated by SIRT1
por: Zhang, Sheng, et al.
Publicado: (2021)

SIRT1 activation and its effect on intercalated disc proteins as a way to reduce doxorubicin cardiotoxicity
por: Podyacheva, Ekaterina, et al.
Publicado: (2022)

Empagliflozin attenuates doxorubicin-induced cardiotoxicity by activating AMPK/SIRT-1/PGC-1α-mediated mitochondrial biogenesis
por: Chen, Meicong
Publicado: (2023)

Dimethyl Fumarate Ameliorates Doxorubicin-Induced Cardiotoxicity By Activating the Nrf2 Pathway
por: Hu, Xiaoliang, et al.
Publicado: (2022)

Berberine Ameliorates Doxorubicin-Induced Cardiotoxicity via a SIRT1/p66Shc-Mediated Pathway
por: Wu, Yan-Zhao, et al.
Publicado: (2019)

Erratum: SIRT1 activation and its effect on intercalated disc proteins as a way to reduce doxorubicin cardiotoxicity
por: Frontiers Production Office,
Publicado: (2023)

Arsenic Trioxide and Resveratrol Show Synergistic Anti-Leukemia Activity and Neutralized Cardiotoxicity
por: Fan, Yuhua, et al.
Publicado: (2014)

Cardioprotective effects of fibroblast growth factor 21 against doxorubicin-induced toxicity via the SIRT1/LKB1/AMPK pathway
por: Wang, Shudong, et al.
Publicado: (2017)

MicroRNA-140-5p aggravates doxorubicin-induced cardiotoxicity by promoting myocardial oxidative stress via targeting Nrf2 and Sirt2
por: Zhao, Lisha, et al.
Publicado: (2017)

Liposomal Resveratrol and/or Carvedilol Attenuate Doxorubicin-Induced Cardiotoxicity by Modulating Inflammation, Oxidative Stress and S100A1 in Rats
por: Alanazi, Abeer M., et al.
Publicado: (2020)

Meteorin-like protein attenuates doxorubicin-induced cardiotoxicity via activating cAMP/PKA/SIRT1 pathway
por: Hu, Can, et al.
Publicado: (2020)

Pharmacological Activity of Flavonoid Quercetin and Its Therapeutic Potential in Testicular Injury
por: Zhang, Xiaohui, et al.
Publicado: (2023)

Choline Protects the Heart from Doxorubicin-Induced Cardiotoxicity through Vagal Activation and Nrf2/HO-1 Pathway
por: Guo, Fuding, et al.
Publicado: (2022)

Prophylactic supplementation of resveratrol is more effective than its therapeutic use against doxorubicin induced cardiotoxicity
por: Shoukry, Heba Samy, et al.
Publicado: (2017)

Protective effect of cafestol against doxorubicin-induced cardiotoxicity in rats by activating the Nrf2 pathway
por: Al-Kenany, Sara A., et al.
Publicado: (2023)

Resveratrol and SIRT1: Antiaging Cornerstones for Oocytes?
por: Grzeczka, Arkadiusz, et al.
Publicado: (2022)

Resveratrol-like Compounds as SIRT1 Activators
por: Ciccone, Lidia, et al.
Publicado: (2022)

PGC1α activation by pterostilbene ameliorates acute doxorubicin cardiotoxicity by reducing oxidative stress via enhancing AMPK and SIRT1 cascades
por: Liu, Dong, et al.
Publicado: (2019)

Overexpressed SIRT6 ameliorates doxorubicin-induced cardiotoxicity and potentiates the therapeutic efficacy through metabolic remodeling
por: Peng, Kezheng, et al.
Publicado: (2023)

Epigenetic Regulation Associated With Sirtuin 1 in Complications of Diabetes Mellitus
por: Wang(a), Jie, et al.
Publicado: (2021)

INKing the Cardiotoxicity Out of Doxorubicin
por: Guo, Zhen, et al.
Publicado: (2023)

Doxorubicin cardiomyopathy is ameliorated by acacetin via Sirt1‐mediated activation of AMPK/Nrf2 signal molecules
por: Wu, Wei‐Yin, et al.
Publicado: (2020)

Activation of miR-34a-5p/Sirt1/p66shc pathway contributes to doxorubicin-induced cardiotoxicity
por: Zhu, Jie-Ning, et al.
Publicado: (2017)

Synergistic cardioprotective effects of melatonin and deferoxamine through the improvement of ferritinophagy in doxorubicin-induced acute cardiotoxicity
por: Hanna, Mira, et al.
Publicado: (2022)

Nrf2-dependent antioxidant response mediated the protective effect of tanshinone IIA on doxorubicin-induced cardiotoxicity
por: Guo, Zhaohui, et al.
Publicado: (2018)

miR-200a Attenuated Doxorubicin-Induced Cardiotoxicity through Upregulation of Nrf2 in Mice
por: Hu, Xiaoping, et al.
Publicado: (2019)

Sirt1 activation by resveratrol is substrate sequence-selective
por: Lakshminarasimhan, Mahadevan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_lgd4ig165afmn27jepshdlc6k2